For example Prof Obermair presented the results of the international LACE trial at the 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) in 2016 in Lisbon Portugal to 2,000 attendees. He presented results of the international LACC trial at the 2018 IGCS conference in Kyoto, Japan to more than 3,000 attendees. He regularly attends the Annual Conference on Women’s Cancer in the United States as well as the Annual Scientific Conference of the Australian Society of Gynaecological Oncologists.
As the chair of the Queensland Centre for Gynaecological Cancer (QCGC) Research, Prof Obermair regularly facilitates the annual QCGC Patent symposium in Brisbane that are attended by almost 200 patients, family members and care givers.
He is regularly invited as a key note and plenary presenter to various conferences in Australia and overseas. As a consequence of the COVID-19 pandemic, many conferences have been postponed or now take place virtually over the web.